What's in Tor Biering-Sørensen's pipeline?

Tor Biering-Sørensen has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Tor Biering-Sørensen's portfolio?

Top competitors by shared drug class: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Assistance Publique - Hôpitaux de Paris, Brigham and Women's Hospital, Chiltern Pesquisa Clinica Ltda, Fluart Innovative Vaccine Ltd, Hungary.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/tor-biering-s-rensen.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Tor Biering-Sørensen — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tor Biering-Sørensen pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Standard-Dose Influenza Vaccine	Standard-Dose Influenza Vaccine	marketed	Inactivated influenza vaccine		Immunology / Infectious Disease
High-Dose Quadrivalent Influenza Vaccine	High-Dose Quadrivalent Influenza Vaccine	marketed	Inactivated influenza vaccine		Immunology / Infectious Disease

Therapeutic area mix

Immunology / Infectious Disease · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Brigham and Women's Hospital · 1 shared drug class
Chiltern Pesquisa Clinica Ltda · 1 shared drug class
Fluart Innovative Vaccine Ltd, Hungary · 1 shared drug class
Folia Biotech Inc. · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Ab&B Bio-tech Co., Ltd.JS · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Tor Biering-Sørensen:

Cite this brief

Drug Landscape (2026). Tor Biering-Sørensen — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/tor-biering-s-rensen. Accessed 2026-05-17.